Benzinga's Top Upgrades, Downgrades For May 24, 2019

Loading...
Loading...

Top Upgrades

  • Guggenheim upgraded Bloomin' Brands Inc BLMN from Neutral to Buy. Bloomin' Brands rose 3.5 percent to $18.86 in pre-market trading.
  • Analysts at JP Morgan upgraded Dow Inc DOW from Underweight to Neutral. Dow rose 1.2 percent to $49.30 in pre-market trading.
  • Analysts at HSBC upgraded Vodafone Group Plc VOD from Hold to Buy. Vodafone shares rose 2.8 percent to $15.99 in pre-market trading.
  • Citigroup upgraded PetroChina Company Limited PTR from Neutral to Buy. PetroChina shares rose 2 percent to $57.45 in pre-market trading.
  • Bank of America upgraded Vale SA VALE from Neutral to Buy. VALE rose 3.2 percent to $12.17 in pre-market trading.
  • JP Morgan upgraded Kratos Defense & Security Solutions, Inc KTOS from Neutral to Overweight. Kratos Defense One rose 5.3 percent to $21.94 in pre-market trading.
  • Credit Suisse upgraded Telefonaktiebolaget LM Ericsson ERIC from Neutral to Outperform. Ericsson shares rose 2.7 percent to $9.98 in pre-market trading.

 

Top Downgrades

  • Morgan Stanley downgraded Constellation Brands, Inc. STZ from Overweight to Equal-Weight. Constellation shares fell 0.8 percent to $204.59 in pre-market trading.
  • Macquarie downgraded SINA Corp SINA from Outperform to Neutral. Sina shares rose 0.1 percent to $42.60 in pre-market trading.
  • RBC Capital downgraded BioCryst Pharmaceuticals, Inc. BCRX from Outperform to Sector Perform. BioCryst Pharmaceuticals shares fell 4 percent to $3.40 in pre-market trading.
  • Piper Jaffray downgraded Big Lots, Inc. BIG from Overweight to Neutral. Big Lots shares fell 4.2 percent to close at $29.31 on Thursday.
  • UBS downgraded Lennox International Inc. LII from Neutral to Sell. Lennox shares fell 0.2 percent to $275.97 in pre-market trading.
  • HSBC downgraded Weibo Corp WB from Hold to Reduce. Weibo rose 0.3 percent to $45.54 in pre-market trading.
  • Morgan Stanley downgraded Veeva Systems Inc VEEV from Overweight to Equal-Weight. Veeva shares fell 0.8 percent to $139.89 in pre-market trading.
  • DA Davidson downgraded Avon Products, Inc. AVP from Buy to Neutral. Avon shares fell 0.3 percent to $3.59 in pre-market trading.
  • Imperial Capital downgraded Axon Enterprise Inc AAXN from Outperform to In-Line. Axon Enterprise shares fell 0.2 percent to $66.90 in pre-market trading.
  • KeyBanc downgraded Cray Inc. CRAY from Overweight to Sector Weight. Cray shares fell 0.5 percent to $35.00 in pre-market trading.


Top Initiations

  • Analysts at Cowen & Co. initiated coverage on Inseego Corp INSG with a Outperform rating. The price target for Inseego is set to $8. Inseego shares closed at $5.19 on Thursday.
  • Analysts at Jefferies initiated coverage on Aphria Inc APHA with a Buy rating. Aphria shares closed at $6.41 on Thursday.
  • Bank of America initiated coverage on CannTrust Holdings Inc CTST with a Buy rating. CannTrust shares closed at $5.69 on Thursday.
  • Deutsche Bank initiated coverage on Markel Corporation MKL with a Hold rating. Markel shares closed at $1,064.59 on Thursday.
  • Needham initiated coverage on Tricida Inc TCDA with a Buy rating. The price target for Tricida is set to $50. Tricida closed at $37.88 on Thursday.
  • Analysts at Oppenheimer initiated coverage on Zoom Video Communications Inc ZM with a Perform rating. Zoom Video Communications closed at $78.76 on Thursday.
  • Baird initiated coverage on Falcon Minerals Corp FLMN with a Outperform rating. Falcon Minerals shares closed at $7.35 on Thursday.
  • Piper Jaffray initiated coverage on PennyMac Mortgage Investment Trust PMT with a Overweight rating. The price target for PennyMac Mortgage Investment Trust is set to $23. PennyMac Mortgage Investment Trust shares closed at $21.14 on Thursday.
  • Analysts at Deutsche Bank initiated coverage on Alleghany Corporation Y with Hold rating. Alleghany shares closed at $684.64 on Thursday.
  • Citigroup assumed coverage on Dicerna Pharmaceuticals Inc DRNA with a Buy rating. The price target for Dicerna Pharmaceuticals is set to $30. Dicerna Pharmaceuticals shares closed at $11.83 on Thursday.
Loading...
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesDowngradesInitiationPre-Market OutlookAnalyst RatingsBuilding ProductsIndustrialsInitiationstop upgrades
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...